Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Veterinary Vaccines Market Size from 2025 to 2034?

The market size for veterinary vaccines has experienced significant expansion in the past few years. An increase from $11.89 billion in 2024 to $12.54 billion in 2025 is expected, with a compound annual growth rate (CAGR) of 5.4%. Factors contributing to this historic growth include the expansion of emerging markets, a rise in spending on pets, enhanced prevalence of diseases, an uptick in the outbreak of poultry diseases, and a surge in the occurrence of zoonotic diseases.

The market for veterinary vaccines is predicted to witness significant expansion in the succeeding years. Its value is projected to escalate to $15.81 billion by 2029, reflecting a compound annual growth rate (CAGR) of 6.0%. Economic growth, the surge in pet insurance penetration, the rise in pet adoption, augmented government initiatives, and enhanced awareness about animal health are contributing factors to this growth during the projected period. The period is also expected to see key trends such as investments in nanoparticles development, an increase in the production of subunit and virus-like particle-based vaccines, manufacturing of vaccines like parvovirus, distemper, and adenovirus to adhere to the mandatory and regular vaccination schedule for pet owners. Technological advancement, increased investment in toxoid and mRNA vaccines, and strategic collaborations and partnerships will also witness considerable investment.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2456&type=smp

What Are the Core Market Drivers Propelling Growth in the Veterinary Vaccines Industry?

The escalating count of animals grappling with various illnesses is heightening the need for vaccines aimed at preventing and curing such conditions, thereby propelling the veterinary vaccines market. Based on estimations from a study conducted by the Animal and Plant Health Agency, there were 3289 new instances of TB herds found in England. Bovine tuberculosis, a chronic illness, typically impacts animals like cattle but can infect all mammals. It induces a general state of sickness, coughing and, ultimately, death. However, it can be effectively treated with specialized antibiotics aimed at exterminating the TB bacteria. The surging instances of animal diseases are anticipated to propel the veterinary vaccines market in the projected period.

How Is the Veterinary Vaccines Market Segmented?

The veterinary vaccines market covered in this report is segmented –

1) By Application: Livestock Vaccines, Companion Animal Vaccines

2) By Vaccine Type: Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types

3) By Disease Type: Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)

Subsegments:

1) By Livestock Vaccines: Bovine Vaccines, Poultry Vaccines, Porcine Vaccines, Small Ruminant Vaccines (Sheep and Goats), Aquaculture Vaccines

2) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Equine Vaccines

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2456&type=smp

Which Regions Are Driving the Next Phase of the Veterinary Vaccines Market Growth?

North America was the largest region in the veterinary vaccines market in 2024. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Market Trends and Innovations Are Shaping the Future of the Veterinary Vaccines Industry?

To expand into new areas and collaborate on research and development projects, firms in the veterinary vaccines market are forming more strategic partnerships and alliances. For example, Merck Animal Health, a pharmaceutical company based in the United States, partnered with Iowa State University, a research university also in the U.S., for a strategic alliance lasting four years in February 2022. The agreement focuses on a range of areas including research and development, manufacturing, business growth, and the discovery of new technologies, all with the common aim of producing imaginative solutions for animal health issues in the United States and globally. MSD Animal Health, a division of Merck & Co based in the United States, also formed a strategic alliance with Vinovo. This partnership allows MSD Animal Health to integrate its unique wide-ranging vaccine product line with Vinovo’s vaccine delivery system for an enhanced vaccination process, ultimately improving bird welfare and reducing vaccine reactions. Similarly, Wageningen bio veterinary research collaborated strategically with Ceva, a company based in Switzerland, to enhance their research on the worldwide threat of emerging and re-emerging diseases in animals.

View the full report here:

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

How Is the Veterinary Vaccines Market Defined and What Are Its Core Parameters?

Veterinary vaccine refers to a biological preparation that stimulates the immune response of an animal against disease in order to reduce animal suffering and the transmission of microorganisms in the animal population and enhance the immunity power of animals by improving animal health, which also prevents the transmission of diseases from animals to humans.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2456

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model